Injective: Bearish signals and oversold technicals spark continued downside

Traders Union
All News
Crypto News
Injective drops 7.90% today to $4.08

Highlights

INJ trades at $4.08, consistently below the MA-20 ($4.89), MA-50 ($4.90), and MA-200 ($9.44), confirming sustained bearish trends across all timeframes.
Momentum indicators including daily/weekly MACD, ADX, Stochastic RSI, CCI, and RSI all signal prevailing seller control and heightened downside risk.
Expected five-day range is $3.80–$4.42, with less than a 20% probability of a move higher; a drop below $3.80 would indicate further downside and lack of support.

Downside momentum persists as technical barriers reinforce seller dominance

Momentum remains weak for INJ, with the Ichimoku Kijun at $5.05 defining dynamic resistance and no clear support identified within the recent trading range. The MACD and ADX both signal a bearish outlook on daily and weekly frames, indicating amplified downside risk. Oversold signals on the Stochastic RSI and CCI align with a downward-trending RSI, all pointing to dominant seller control, while Bull/Bear Power confirms that sellers are dictating intraday price action. Volatility is elevated, and the price is trading close to today's session low with pressure evident since the open.

Further declines likely as bearish indicators drive scenario outlook

For the next five trading days, INJ is expected to move within a typical volatility band of $3.80 – $4.42, aligned with recent swings and prevailing momentum. The chance of a substantial price increase is under 20%, and the likelihood of continued declines is greater, based on continued bearish signals across all indicators. The baseline scenario sees consolidation inside this range. If INJ breaks above $4.42, a modest rebound may emerge; however, any move below $3.80 may lead to further downside, as there is no clear long-term support visible.

Anton Kharitonov, expert at Traders Union, sees persistent bearish signals dominating the Injective (INJ) chart. Technical indicators remain weak, with price action stuck below key moving averages and no credible support nearby. He notes the likelihood of further declines unless $4.42 is reclaimed. "I remain cautious on INJ — unless the price breaks decisively above $4.42, sellers are in clear control."

Previously it was reported that Injective remains in a bearish trend, consistently trading below its major moving averages with weak momentum indicators and resistance at the $5.05 level. The asset is expected to move sideways in the coming week within a narrow range, with limited breakout probability unless technical indicators improve significantly.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.